Genotyping in a validation cohort of 191 lean individuals with NAFLD and 105 lean controls revealed a threefold higher risk of NAFLD in carriers of the rs7946 risk genotype, but no significant differences were found for the OSBPL10 variant. This evidence concerns the gene OSBPL10 and metabolic dysfunction-associated steatotic liver disease.